Physiologic and metabolic influences on enterohepatic recirculation: Simulations based upon the disposition of valproic acid in the rat
- 1 April 1991
- journal article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 19 (2) , 189-225
- https://doi.org/10.1007/bf01073869
Abstract
The potential influence of alterations in several physiologic processes (hepatocellular egress, biliary excretion, gastrointestinal transit) and biotransformation steps (oxidative metabolism, glucuronidation) on the disposition of agents subject to significant enterohepatic recirculation (ER) via the glucuronide conjugate was examined in a series of simulation experiments. The model of ER developed was based upon the disposition of valproic acid (VPA) and valproate glucuronide (VPA-G) in the rat. The systemic disposition of VPA was simulated following changes in several processes contributing to (or competing with) ER: hepatic oxidative metabolism, hepatic glucuronidation, sinusoidal egress of glucuronide conjugate, canalicular egress of glucuronide conjugate, and gastrointestinal transit. Changes in the formation clearance of VPA-G resulted in a less than proportional change in systemic clearance of VPA, whereas changes in oxidative metabolism led to a greater than proportional change in systemic clearance. Furthermore, alterations in hepatocellular egress of VPA-G affected the disposition of the parent compound, suggesting that drug interactions or disease state effects on metabolite transport may be misinterpreted as effects at the level of metabolite formation. Analytical methods are proposed to recover the intrinsic kinetic parameters (formation clearances of metabolites, renal clearance of parent, volume of distribution) in the presence of ER from the systemic disposition of the parent alone.Keywords
This publication has 25 references indexed in Scilit:
- The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: The reversible metabolism of methylprednisolone and methylprednisone in rabbitsJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Accumulation and Time to Steady State for Drugs Subject to Enterohepatic Cycling: a Stimulation StudyJournal of Pharmaceutical Sciences, 1985
- Metabolism and enterohepatic circulation of benzo(a)pyrene-4,5-epoxide in the ratXenobiotica, 1985
- Pharmacokinetic Analysis of Concentration-Time Data Obtained Following Administration of Drugs that are Recycled in the BileJournal of Pharmaceutical Sciences, 1984
- Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulationJournal of Pharmacokinetics and Biopharmaceutics, 1982
- A Time-Lag Model for Pharmacokinetics of Drugs Subject to Enterohepatic CirculationJournal of Pharmaceutical Sciences, 1982
- A linear model of reversible metabolism and its application to bioavailability assessmentJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Pharmacokinetics of Doxycycline ReabsorptionJournal of Pharmaceutical Sciences, 1980
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the ratJournal of Pharmacokinetics and Biopharmaceutics, 1978